Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00912652 · ClinicalTrials.gov registry record · NA
Rural Lifestyle Intervention Treatment Effectiveness Trial
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 612
- Enrollment target
NCT00912652: Completed NA study, sponsored by University of Florida.
NCT00912652 is a NA study that has completed, run by University of Florida. The registered enrollment target is 612 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00912652, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 612 participants
- Enrollment target
Study Summary
More and more Americans are becoming overweight. The rates of overweight are especially high in rural areas of the country. Until now, there has been little access to weight management programs in rural areas. This study will examine ways to help individuals from rural counties to manage weight and improve fitness. To do this, three doses of lifestyle treatment (Low, Moderate and High)will be compared to an education control condition. Our principal hypothesis is that both the Moderate and High conditions will have greater weight loss at two years than either the Low or Control conditions.
Interventions
- BEHAVIORAL Health Education Control
- BEHAVIORAL lifestyle intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 612 participants |
| Start Date | 2008-06 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT00912652 record still lists
NCT00912652 is an interventional study that assigns participants to a tested intervention. The registered 612 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (56% lower).
The record links to 0 conditions, and to 2 interventions - of which Health Education Control is the first listed.
NCT00912652 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00912652 about?
NCT00912652 is a clinical study titled "Rural Lifestyle Intervention Treatment Effectiveness Trial". More and more Americans are becoming overweight. The rates of overweight are especially high in rural areas of the country. Until now, there has been little access to weight management programs in rural areas. This study will examine ways to help individuals from rural counties to manage weight and ...
What is the current status of trial NCT00912652?
This trial is currently completed. It is a NA study. The enrollment target is 612 participants. The study started on 2008-06. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00912652?
The interventions under investigation include: Health Education Control (BEHAVIORAL), lifestyle intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00912652?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00912652's enrollment target sits among peer trials
612 161st of 2000 higher than 1,840 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04224493 · 612 participants · Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
- NCT04590326 · 612 participants · Phase 1
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- NCT06266416 · 612 participants · NA
IMARA for Black Male Caregivers and Girls Empowerment (IMAGE)
- NCT01810913 · 613 participants · Phase 2
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia